TD Private Client Wealth LLC Raises Position in DaVita Inc. (NYSE:DVA)

TD Private Client Wealth LLC raised its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 1,483.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 4,688 shares of the company's stock after acquiring an additional 4,392 shares during the quarter. TD Private Client Wealth LLC's holdings in DaVita were worth $701,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. Thrivent Financial for Lutherans raised its position in DaVita by 49.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 8,131 shares of the company's stock worth $1,333,000 after purchasing an additional 2,688 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of DaVita in the third quarter valued at about $923,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of DaVita during the third quarter worth about $2,042,000. Advisors Asset Management Inc. lifted its stake in shares of DaVita by 34.3% in the third quarter. Advisors Asset Management Inc. now owns 18,201 shares of the company's stock worth $2,984,000 after acquiring an additional 4,647 shares during the period. Finally, Raymond James Trust N.A. bought a new stake in DaVita in the third quarter valued at approximately $223,000. Institutional investors own 90.12% of the company's stock.

DaVita Stock Up 0.9 %

DVA stock traded up $1.36 during trading on Thursday, reaching $152.73. 410,680 shares of the stock were exchanged, compared to its average volume of 783,449. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $125.64 and a twelve month high of $179.60. The firm's 50 day moving average is $157.96 and its 200 day moving average is $157.53. The firm has a market cap of $12.22 billion, a P/E ratio of 14.22, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on DVA. Cowen restated a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. StockNews.com lowered DaVita from a "buy" rating to a "hold" rating in a research report on Friday, March 21st. Finally, Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.